ALLERGAN AUSTRALIA PTY LIMITED

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides

Phase 3

Completed

Conditions: Forehead Rhytides
Glabellar Rhytides

Interventions: Drug: Normal Saline
Biological: OnabotulinumtoxinA

First Posted Date: 2014-10-10

Last Posted Date: 2019-01-08

Lead Sponsor: Allergan

Target Recruit Count: 421

Registration Number: NCT02261467

Locations: 🇺🇸
Laser & Skin Surgery Center of Indiana, Carmel, Indiana, United States
🇨🇦
Sweat Clinics of Canada, Toronto, Ontario, Canada
🇨🇦
Carruthers Dermatology Centre, Vancouver, British Columbia, Canada

and more 13 locations

Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

Phase 3

Completed

Conditions: Ocular Hypertension
Glaucoma, Open-Angle

Interventions: Drug: Bimatoprost SR
Drug: Timolol Vehicle (placebo)

First Posted Date: 2014-09-26

Last Posted Date: 2021-07-28

Lead Sponsor: Allergan

Target Recruit Count: 528

Registration Number: NCT02250651

Locations: 🇨🇦
Sunnybrook Research Institute, Toronto, Ontario, Canada
🇺🇸
Mark B. Kislinger, MD, Inc., Glendora, California, United States
🇺🇸
Southern California Eye Physicians and Surgeons, Los Alamitos, California, United States

and more 110 locations

Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension

Phase 3

Completed

Conditions: Glaucoma, Open-Angle
Ocular Hypertension

Interventions: Drug: Bimatoprost SR
Drug: Timolol Vehicle (placebo)

First Posted Date: 2014-09-25

Last Posted Date: 2020-06-11

Lead Sponsor: Allergan

Target Recruit Count: 594

Registration Number: NCT02247804

Locations: 🇺🇸
Nature Coast Clinical Research, Crystal River, Florida, United States
🇺🇸
Montebello Medical Eye Center Inc., Montebello, California, United States
🇺🇸
Glaucoma Institute of Beverly Hills, Los Angeles, California, United States

and more 103 locations

Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Completed

Conditions: Crow's Feet Lines
Lateral Canthal Lines

Interventions: Biological: Botulinum Toxin Type A

First Posted Date: 2014-09-25

Last Posted Date: 2019-07-05

Lead Sponsor: Allergan

Target Recruit Count: 667

Registration Number: NCT02248844

Locations: 🇰🇷
Dr. Robbin Clinic, Gangnam-gu, Seoul, Korea, Republic of

A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm

Completed

Conditions: Cervical Dystonia
Blepharospasm

Interventions: Other: No Intervention

First Posted Date: 2014-09-22

Last Posted Date: 2016-01-08

Lead Sponsor: Allergan

Target Recruit Count: 44

Registration Number: NCT02245958

BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis

Phase 2

Completed

Conditions: Osteoarthritis

Interventions: Biological: onabotulinumtoxinA
Drug: Normal Saline

First Posted Date: 2014-09-03

Last Posted Date: 2017-05-31

Lead Sponsor: Allergan

Target Recruit Count: 176

Registration Number: NCT02230956

Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris

Phase 1

Completed

Conditions: Acne Vulgaris

Interventions: Drug: tazarotene gel 0.1%
Drug: AGN-190168 Formulation 2
Drug: AGN-190168 Formulation 1
Drug: tazarotene cream 0.1%

First Posted Date: 2014-08-15

Last Posted Date: 2015-04-30

Lead Sponsor: Allergan

Target Recruit Count: 78

Registration Number: NCT02218034

Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia

Phase 2

Completed

Conditions: Presbyopia

Interventions: Drug: AGN-199201
Drug: AGN-199201 Vehicle
Drug: AGN-190584

First Posted Date: 2014-07-23

Last Posted Date: 2015-12-03

Lead Sponsor: Allergan

Target Recruit Count: 65

Registration Number: NCT02197806

BOTOX® in the Treatment of Crow's Feet Lines in China

Phase 3

Completed

Conditions: Crow's Feet Lines
Lateral Canthal Lines

Interventions: Biological: botulinum toxin Type A
Drug: Normal Saline

First Posted Date: 2014-07-21

Last Posted Date: 2016-03-14

Lead Sponsor: Allergan

Target Recruit Count: 417

Registration Number: NCT02195687

Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults

Phase 4

Completed

Conditions: Migraine Disorders

Interventions: Biological: onabotulinumtoxinA
Drug: Topiramate

First Posted Date: 2014-07-16

Last Posted Date: 2018-06-07

Lead Sponsor: Allergan

Target Recruit Count: 282

Registration Number: NCT02191579

Locations: 🇺🇸
Kansas City Bone and Joint Clinic, Overland Park, Kansas, United States
🇺🇸
Newport Beach Clinical Research Associates, Inc., Newport Beach, California, United States
🇺🇸
California Headache and Balance Center, Fresno, California, United States

and more 29 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy